Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Abstract Text:

    laura y mcgirtLaura Y McGirt,kavitha vasagarKavitha Vasagar,laura m goberLaura M Gober,sarbjit s sainiSarbjit S Saini,lisa a beckLisa A Beck,

    BACKGROUND: Antihistamines are the standard treatment for chronic idiopathic urticaria (CIU). For patients whose urticaria is unresponsive to antihistamines, the treatment options are limited. During the previous decade, there have been several case reports demonstrating success with sulfasalazine therapy. In this article, we present a case series evaluating sulfasalazine therapy for antihistamine-unresponsive CIU. OBSERVATIONS: Nineteen patients with antihistamine-unresponsive CIU were treated with sulfasalazine between 2002 and 2005. During sulfasalazine therapy, 14 patients (74%) reported significant improvement, 4 patients (21%) reported minimal improvement but were not satisfied with their symptom relief, and 1 patient (5%) reported a worsening of symptoms. Of the 13 patients who required systemic steroids to control their urticaria, all were able to reduce or discontinue steroid use during sulfasalazine therapy. Although 7 patients (37%) had adverse effects (eg, nausea, headache, mild or transient leukopenia, and transaminitis) that were thought to be caused by the use of sulfasalazine, they all kept taking the drug. CONCLUSIONS: This case series demonstrates that sulfasalazine can be a successful and safe treatment option for patients with CIU who have not responded adequately to treatment with antihistamines. Sulfasalazine was steroid sparing in all subjects who were steroid dependent.

    Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Publishing Authors By Initials

    ly mcgirtLY McGirt,k vasagarK Vasagar,lm goberLM Gober,ss sainiSS Saini,la beckLA Beck,

    For similar skin and connective tissue diseases: skin diseases: skin diseases, vascular: urticaria research abstracts see: skin and connective tissue diseases: skin diseases: skin diseases, vascular: urticaria research

    PUBMED ID PMID:

    MEDLINE DATE:

    Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Archives of dermatology

    VOLUME: 142

    Page Numbers: 1337-42

    Journal Abbreviation:

    ISSN: 0003-987X

    DAY: 3

    MONTH: Oct

    YEAR: 2006

    Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372433

    Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Keywords Mesh Terms:

    KEYWORDS: Urticaria

    MESH TERMS: pathology

    Chemical & Substance for Abstract: Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Information

    Substance Name: Sulfasalazine

    Registry Number: 599-79-1

    Grant and Affiliation Information for Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

    AFFILIATION: Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: AI50024

    ACRONYM: AI

    MEDLINETA: Arch Dermatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News